Free Trial

iHuman Inc. Sponsored ADR (NYSE:IH) Short Interest Update

iHuman logo with Consumer Discretionary background

Key Points

  • iHuman Inc. experienced a significant reduction in short interest, dropping to just 200 shares as of August 31, a decline of 93.5% from earlier in the month.
  • Recent institutional activity includes Virtu Financial and Acadian Asset Management each acquiring new positions in iHuman, while Citadel Advisors increased its stake by 24.3%.
  • iHuman's stock price rose 0.7% to $2.93, with its market cap currently at $152.37 million.
  • Five stocks to consider instead of iHuman.

iHuman Inc. Sponsored ADR (NYSE:IH - Get Free Report) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 200 shares, a decline of 93.5% from the August 15th total of 3,100 shares. Currently, 0.0% of the company's shares are short sold. Based on an average daily volume of 31,600 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 31,600 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company's shares are short sold.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Virtu Financial LLC acquired a new position in iHuman in the 1st quarter valued at $26,000. Acadian Asset Management LLC acquired a new position in iHuman in the 1st quarter valued at $32,000. Finally, Citadel Advisors LLC grew its position in shares of iHuman by 24.3% in the fourth quarter. Citadel Advisors LLC now owns 47,683 shares of the company's stock valued at $81,000 after purchasing an additional 9,314 shares during the last quarter. Institutional investors and hedge funds own 4.92% of the company's stock.

iHuman Stock Up 0.7%

Shares of IH stock traded up $0.02 during trading hours on Thursday, reaching $2.93. 12,151 shares of the stock traded hands, compared to its average volume of 43,644. iHuman has a 1-year low of $1.47 and a 1-year high of $3.60. The business has a fifty day moving average price of $2.75 and a 200 day moving average price of $2.43. The firm has a market capitalization of $152.37 million, a PE ratio of 10.85 and a beta of 0.39.

iHuman (NYSE:IH - Get Free Report) last issued its earnings results on Thursday, June 26th. The company reported $0.07 earnings per share for the quarter. The company had revenue of $29.00 million for the quarter. iHuman had a return on equity of 11.00% and a net margin of 11.44%.

iHuman Company Profile

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in iHuman Right Now?

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.